Sung S S, Nelson R S, Silverstein S C
J Cell Biol. 1983 Jan;96(1):160-6. doi: 10.1083/jcb.96.1.160.
We have examined the effects of various mannans, glycoproteins, oligosaccharides, monosaccharides, and sugar phosphates on the binding and phagocytosis of yeast cell walls (zymosan) by mouse peritoneal macrophages. A phosphonomannan (PO(4):mannose ratio = 1:8:6) from kloeckera brevis was the most potent inhibitor tested; it inhibited binding and phagocytosis by 50 percent at concentrations of approximately 3-5 mug/ml and 10 mug/ml, respectively. Removal of the phosphate from this mannan by mild acid and alkaline phosphatase treatment did not appreciably reduce its capacity to inhibit zymosan phagocytosis. The mannan from saccharomyces cerevisiae mutant LB301 inhibits phagocytosis by 50 percent at 0.3 mg/ml, and a neutral exocellular glucomannan from pichia pinus inhibited phagocytosis by 50 percent at 1 mg/ml. Cell wall mannans from wild type S. cervisiae X2180, its mnn2 mutant which contains mannan with predominantly 1(arrow)6- linked mannose residues, yeast exocellular mannans and O-phosphonomannans were less efficient inhibitors requiring concentrations of 1-5 mg/ml to achieve 50 percent reduction in phagocytosis. Horseradish peroxidase, which contains high-mannose type oligosaccharides, was also inhibitory. Mannan is a specific inhibitor of zymosan binding and phagocytosis. The binding and ingestion of zymosan but not of IgG- or complement-coated erythrocytes can be obliterated by plating macrophages on substrates coated with poly-L-lysin (PLL)-mannan. Zymosan uptake was completely abolished by trypsin treatment of the macrophages and reduced by 50-60 percent in the presence of 10 mM EGTA. Pretreatment of the macrophages with chloroquine inhibited zymosan binding and ingestion. These results support the proposal that the macrophage mannose/N-acetylglucosamine receptor (P. Stahl, J.S. Rodman, M.J. Miller, and P.H. Schlesinger, 1978, Proc. Natl. Acad. Sci. U.S.A. 75:1399-1403, mediates the phagocytosis of zymosan particles.
我们研究了各种甘露聚糖、糖蛋白、寡糖、单糖和糖磷酸盐对小鼠腹腔巨噬细胞结合和吞噬酵母细胞壁(酵母聚糖)的影响。来自短梗克洛酵母的一种磷酸甘露聚糖(PO(4):甘露糖比例 = 1:8:6)是所测试的最有效的抑制剂;它分别在浓度约为3 - 5微克/毫升和10微克/毫升时抑制50%的结合和吞噬作用。通过温和的酸和碱性磷酸酶处理从这种甘露聚糖中去除磷酸盐,并没有明显降低其抑制酵母聚糖吞噬作用的能力。来自酿酒酵母突变体LB301的甘露聚糖在0.3毫克/毫升时抑制50%的吞噬作用,来自松毕赤酵母的一种中性胞外葡糖甘露聚糖在1毫克/毫升时抑制50%的吞噬作用。来自野生型酿酒酵母X2180的细胞壁甘露聚糖、其mnn2突变体(含有主要为1(→)6连接的甘露糖残基的甘露聚糖)、酵母胞外甘露聚糖和O - 磷酸甘露聚糖是效率较低的抑制剂,需要1 - 5毫克/毫升的浓度才能使吞噬作用降低50%。含有高甘露糖型寡糖的辣根过氧化物酶也具有抑制作用。甘露聚糖是酵母聚糖结合和吞噬作用的特异性抑制剂。通过将巨噬细胞接种在涂有聚 - L - 赖氨酸(PLL) - 甘露聚糖的底物上,可以消除酵母聚糖的结合和摄取,但不会消除IgG或补体包被的红细胞的结合和摄取。用胰蛋白酶处理巨噬细胞可完全消除酵母聚糖的摄取,在10 mM乙二醇双乙胺四乙酸(EGTA)存在下摄取减少50 - 60%。用氯喹预处理巨噬细胞可抑制酵母聚糖的结合和摄取。这些结果支持了巨噬细胞甘露糖/N - 乙酰葡糖胺受体(P. Stahl、J.S. Rodman、M.J. Miller和P.H. Schlesinger,1978年,美国国家科学院院刊75:1399 - 1403)介导酵母聚糖颗粒吞噬作用的提议。